Anthropic just teamed up with Goldman Sachs and Blackstone to launch a $1.5 billion AI venture targeting private equity-owned companies—signaling that AI monetization is moving decisively beyond Silicon Valley and into mainstream corporate finance. This is a landmark moment for understanding where the real AI money is flowing. Today&#x27;s Stocks &amp; Topics: CVS Health Corporation (CVS), Market Wrap, Domino&#x27;s Pizza, Inc. (DPZ), The Arms Race for AI Capital: How Anthropic, Goldman, and Private Equity Are Reshaping Investing, Value Stocks, Invesco S&amp;P SmallCap Energy ETF (PSCE), Key Benchmark Numbers: Treasury Yields, Gold, Silver, Oil and Gasoline, Rising Cost of Jet Fuel, FactSet Research Systems Inc. (FDS), KPP Newsletter, Memory Chips Stocks. Our Sponsors: * Check out Anthropic and use my code Claude.ai/invest for a great deal: https://www.anthropic.com * Check out Chilipad and use my code INVEST for a great deal: https://sleep.me * Check out Chilipad and use my code sleep.me/INVEST for a great deal: https://sleep.me * Check out Plaud AI and use my code INVEST for a great deal: https://plaud.ai * Check out Quince and use my code quince.com/invest for a great deal: https://www.quince.com * Check out Quince and use my code quince.com/invest for a great deal: https://www.quince.com * Check out TruDiagnostic and use my code INVEST20 for a great deal: https://www.trudiagnostic.com Advertising Inquiries: https://redcircle.com/brands

The Arms Race for AI Capital: How Anthropic, Goldman, and Private Equity Are Reshaping Investing

InvestTalk

# Full Transcript

**Podcast:** InvestTalk

## Participants

- **Luke Guerrero** (KPP Financial)
- **Justin Klein** (KPP Financial)

## Transcript

On Radio, on YouTube, streaming live on InvestTalk.com, and for our podcast subscribers, this is InvestTalk, independent thinking, shared success. InvestTalk is made possible by KPP Financial, a registered investment advisor firm serving clients throughout the United States. Here is KPP Financial Portfolio Manager, Luke Guerrero.

Welcome, everybody, to the Friday, May 8th, 2026 edition of InvestTalk. I'm your host, Luke Guerrero, and I'll be with you over the next 50 or so minutes while we round out the week and send ourselves off into what hopefully is a calm and relaxing weekend. As always, we've got a bunch of stories to talk about today. We have plenty of questions to answer. Before we get started with that, I do want to remind you that we did wrap up our latest InvestTalk.com, and we'll be back to you next time.

InvestTalk Wealth Webinar on Wednesday, where we talked all about inflation. As always, we did about a 50-50 split between a presentation on how you can orient your portfolio in inflationary times, and then the other half answered finance and investment questions from our audience. If you missed the webinar, if you missed the webinar, if it's not available yet, it should be available soon over on our YouTube channel. Just head over to YouTube and search InvestTalk with two Ts.

Now, in just a bit, we'll talk about today's market performance and run down those show topics, but why don't we start off this show by answering a fresh-collar question? I'm calling in about CVS. I've bought a little bit here, wanting to know what you guys think about kind of going all in or keep buying little by little as it keeps coming down. Where do you see, obviously, your major support levels? Any information on what you think about buying in on it would be appreciated. Thanks.

CVS is, of course, the behemoth CVS Health Corporation. It is an integrated healthcare giant. They operate under three segments, their healthcare benefits, so Aetna Insurance, as well as Medicare Advantage, their health services, so think Caremark, their prescriptions, and their pharmacy and consumer wellness.

That's their 9,900 retail pharmacies globally. They are the only company that is actually simultaneously a top three insurer, a top three PBM, and the largest pharmacy chain in America. So it's a pretty large company, $111 billion market cap company, about 185.7 in total liabilities.

Now, they recently reported earnings on May 6th, which was two days ago, where they had a massive beat on both revenue and earnings per share, as well as raising full-year guidance. But in spite of that, stocks still fell 1.6% in earnings day. Then today it was up 3.65%. But regardless, in the past month or so, since the beginning of April, prices risen from about $73 per share to about $90.55.

And year to date, it's up 14%. Now, compare that ...

The Arms Race for AI Capital: How Anthropic, Goldman, and Private Equity Are Reshaping Investing

Transcript

Built for investment professionals

Every day you wait, your competitors are finding
edge in conversations you're not hearing.

The Arms Race for AI Capital: How Anthropic, Goldman, and Private Equity Are Reshaping Investing

Transcript

Built for investment professionals

Every day you wait, your competitors are findingedge in conversations you're not hearing.

Every day you wait, your competitors are finding
edge in conversations you're not hearing.